Expert voices

Dr Barbara Riond from the Clinical Laboratory of the Vetsuisse Faculty speaks about how their XN-1000V supports quality and workflow efficiency in routine practice as well as veterinary research diagnostics.

Anaemia is a very common disorder among small animals and something veterinary practices must address quite often. The early differentiation of the underlying cause of canine anaemia is one of the biggest diagnostic challenges that veterinary clinicians currently face.

IDEXX is one of the largest veterinary laboratories in Europe. Lab Manager Medine Ilbaz talks on the pitfalls of tiger blood and how the company at the Kornwestheim site is saving time with the XN-V Series.

Learn more about how the Sysmex XN-31 speeds up malaria analysis at Dr Wisplinghoff’s laboratory in Cologne

Dr Simon Onsongo discusses the malaria situation in his region in Kenya and why his hospital is evaluating the performance of the Sysmex XN-31 to diagnose and treat patients suspected of malaria in a more efficient way.

We discuss with Dr Vanessa Nivaggioni the development of a new algorithm for hereditary RBC diseases with the aim to guide the use of complementary examinations for the diagnosis.

Dr Eloisa Urrechaga, a senior expert in clinical chemistry at Biocruces Bizkaia Health Research Institute, Barakaldo in Spain shares her passion for pushing boundaries of laboratory medicine for better diagnosis and management of sepsis.

Dr Reid Aikin from the WADA explains how an Athlete Biological Passport works and which haematologic parameters are of importance.

In this interview, PD Dr. med Hönemann points out the benefits of the parameter RET-He in clinical practice of the anaemia outpatient clinic at the Marienhospital Vechta, Germany.

Patient blood management is a project close to Dr Stefanie Grützner’s heart. In this interview, the director of the Institute of Transfusion Medicine and Haemostaseology describes how Augsburg University Hospital implements this concept.

Watch Dr Jürgen Riedl, clinical chemist and haematology expert in The Netherlands, describing digital imaging as the standardised way to perform morphology analysis and apply it as a pathology filter to distinguish disease from non-disease.

Read about the improvements that the Lovisenberg Diaconal Hospital in Norway experienced when they integrated the Tosoh G11 with the Sysmex automated haematology XN-Series. And how automation of the HbA1c analysis significantly improved the lab workflow, freeing up resources for other tasks.

Read how Bettina Madsen-Mogensen from Holbæk hospital in Denmark describes the integration of the Tosoh G11 for HbA1c testing in their XN-9000 automation solution.

An update on the current challenges of transfusion medicine against the background of globalisation and why patient blood management on a European level will help to maintain patient safety

A laboratory perspective on the diagnostic benefit of RET-He and Delta-He in the diagnosis and monitoring of inflammation and systemic bacterial infections.

A clinical perspective on the past, present and future importance of the markers Hypo-He, RET-He and Delta-He as monitoring tools of iron supply to the bone marrow in haemodialysis patients.

The XN-Series with integrated WPC channel and XN stem cell application helps in finding the ideal time for stem cell apheresis.

Dr Cohen from Geneva University Hospital speaks about how the CBC-O application helps to optimize result reporting for MCHC elevated samples in the haematology lab.

Learn about how Sysmex's haemostasis testing solutions are implemented at the Montpellier University Hospital in France.

How flow cytometry improves the workflow in microbiology and allows early diagnoses as well as targeted antibiotics treatment programmes

Microalbuminuria increasingly becoming the focus of attention. Up to now, the diagnosis has been complicated and costly. New test strips from Sysmex make the process much cheaper and easier.

Liquid Biopsy Impact latest article explores insights from Prof. Dr. Wendelin Schramm on the cost-effectiveness of NGS-based liquid biopsy for monitoring colorectal cancer (CRC) recurrence. The discussion highlights its potential to reduce healthcare costs, improve patient outcomes, and address the clinical and economic challenges of CRC care.

As we enjoy the summer and raise awareness about melanoma, this month’s Impact discusses the latest scientific data on patient management. Hear directly from Dr. Isabel Heidrich and Dr. Christoffer Gebhardt about how liquid biopsy can be a valuable ally in the fight against melanoma.

Join us for an engaging discussion on the most clinically relevant and updated uses of liquid biopsy in routine practice and the latest advancements in this innovative field. The Impact Series brings you insightful conversations on cutting-edge scientific data, routine applications, and exclusive interviews with specialists. We'll also explore the economic aspects of implementing this transformative tool in healthcare.

Follow Olympic swimmer Maarten van der Weijden's inspiring battle with leukemia and his triumphant return. Witness the power of resilience and advanced diagnostics. Watch now.

In this insightful video, a renowened surgical oncologist at Zuyerland, delves into the transformative role of OSNA (One-Step Nucleic Acid Amplification) in advancing breast cancer diagnosis.

Would you like to know more about how liquid biopsy is improving the healthcare journey of a cancer patient? Watch our informative video featuring experts Prof. Gebhardt, Dr Heidrich and Prof. Payen-Gay as they explain the concept of liquid biopsy and its transformative impact on patient care.

Sentinel’s CALiaGold® pierceTube surpasses the former version with prolonged stability prior to faecal sampling, enableing patients’ home sampling. Dr Marianne Schoorl, Manager of Quality at the North Netherland’s top clinical teaching hospital in Alkmaar, shares her experience with the diagnosis of IBS and IBD using the CALiaGold® immunoassay and the SENTiFIT® 270 Analyser.

The Plasma-SeqSensei™ IVD Kits are liquid biopsy test kits which enable response monitoring, recurrence monitoring and minimal residual disease detection in cancer patients.

The team of Dr Bhuwnesh Agrawal is at the forefront of the revolution in oncology diagnostics. Liquid biopsy (LB), the method which lies at the heart of the products offered by Sysmex Inostics GmbH, where Dr Agrawal works, promises to provide insights on cancer using just a few millilitres of blood.

Many patients undergoing chemotherapy suffer side effects in silence. Dr Sarita Retief explains that this isn’t how it should be and implores patients to voice their chemo side effects.

Kristin Smith, a patient navigator in oncofertility care, enlightens us on how she assists newly diagnosed cancer patients with their fertility preservation journey, at Northwestern University’s Lurie Cancer Center, in the USA. Note, this article pertains to practices in America.

We learn the ins and outs of the colostomy surgery procedure.

Dr. Vicente Peg from the Pathology Services at Vall d’Hebron University Hospital explains the advantage of molecular lymph node staging with OSNA, the prognostic value of TTL as well as the outcome of the PLUTTO validation study.

Magseed was launched in the United States at the end of 2016 and has already benefitted over 3,000 patients. The Multidisciplinary Breast Centre of the University Hospital Leuven was one of the first major institutions in Europe to use the magnetic marker in its clinical practice. Surgical Oncologist Prof. Ann Smeets talks about her experience.

Dr François Vergez, Toulouse University Hospital, shares his experience in applying automation to sample preparation at the ESCCA 2021 Virtual.

Robert Lemke from the IMD Berlin talks about the new Sample Preparation System PS-10

The developing threat of antimicrobial resistance on global health is proving to be challenging. Sysmex Europe outlines the burden and prevention of antimicrobial resistance and how the diagnostic industry is crucial in the fight against AMR.

Antimicrobial resistance (AMR) is a major global health crisis, but there are still areas where diagnostics can help hinder it.

Dr José Medina-Polo gives us insight on the status of antimicrobial resistance in the field of urology and how education is the biggest hurdle we have in addressing it, whether on the medical specialist level or on a public policy level.

Interview with Dr med. Peter Keller, Deputy Head of Diagnostics at the Institute for Infectious Diseases at Universität Bern in Switzerland, about his experiences with AMR.

Prof. Dr Shingo Yamamoto is the Head of the Urology Department at the Hospital of Hyogo College of Medicine in Nishinomiya, Japan. He outlines the current status of AMR (antimicrobial resistance) in Japan and future measures that are needed to fight it.

Dr Wai-kit Ma is Head of Urology and Department of Surgery at the Princess Margaret Hospital. He outlines some first-hand experience with AMR, how important microbiologists are in the fight against AMR and some tips the general public should be aware of.

H. Hermann Droest is Head of Primary Care & Essential Healthcare at Sysmex Europe GmbH. He tells us a little bit about why the topic of Primary Care and infections plays a role in your work at Sysmex

Why big data is a great opportunity for the future of laboratory medicine and economization of the field must be more than just keeping costs low – a conversation about being close to the patient.

The Vithas veterinary lab in Spain makes use of the Sysmex XN-1000V with PLT-F to find new species for research.